Ramón V. Tiu - Concepedia

Author

Ramón V. Tiu

Cleveland Clinic

Also Known As

Eric D. Hsi, Josef Prchal, R Tiu, R V Tiu, R. Tiu, R. V. Tiu, R.V. Tiu, Ramon Tiu, Ramon V Tiu, Ramon V. Tiu

327

Publications

9.1K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Johns Hopkins University Moffitt Cancer Center The University of Texas MD Anderson Cancer Center Eli Lilly (United States)

About

Ramón V. Tiu is an author at Cleveland Clinic specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	30	2.4K
2	Health Sciences	9	9	681
3	Natural Sciences	2	2	58
4	Public Health	2	2	115
5	Allergy	1	1	116

Ramón V. Tiu

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms A. Jankowska, Hadrian Szpurka, Ramón V. Tiu, Blood	2009	375
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis Hideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, Blood	2012	369
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A A. Jankowska, Hideki Makishima, Ramón V. Tiu, Blood	2011	320
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, The Lancet Haematology Hematological MalignancyAntifibrotic TherapyOncologyMulticentre StudyHematology	2017	316
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML Lukasz P. Gondek, Ramón V. Tiu, Christine L. O’Keefe, Blood CytogeneticsMixed-phenotype Acute LeukemiaGeneticsPathologyEpigenetics	2007	309
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms Fabı́ola Traina, Valeria Visconte, Paul Elson, Leukemia Hematological MalignancyMolecular MutationsMedicineTreatment ResponseDnmt Inhibitors	2013	283
Mutations of E3 Ubiquitin Ligase <i>Cbl</i> Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies Hideki Makishima, Heather Cazzolli, Hadrian Szpurka, Journal of Clinical Oncology	2009	212
Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation Hadrian Szpurka, Ramón V. Tiu, Gurunathan Murugesan, Blood	2006	207
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms Sa A. Wang, Robert P. Hasserjian, Patricia S. Fox, Blood	2014	204
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies Ramón V. Tiu, Lukasz P. Gondek, Christine L. O’Keefe, Blood	2011	196

Page 1